Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02450643 · ClinicalTrials.gov registry record · NA
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT02450643 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 83 participants.
The verdict
NCT02450643, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
Infants/children with cow's milk allergy will take part in 2 double-blinded placebo-controlled food challenges (DBPCFC) of 2 extensively hydrolyzed formulas in random order. If both food challenges are passed, subjects will be asked to consume the Test formula in an at-home open challenge for 7 days.
Interventions
- OTHER Test extensively hydrolyzed formula
- OTHER Control extensively hydrolyzed formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02450643
The ClinicalTrials.gov registry entry for NCT02450643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Test extensively hydrolyzed formula is the first listed.
NCT02450643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02450643 about?
NCT02450643 is a clinical study titled "Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula". Infants/children with cow's milk allergy will take part in 2 double-blinded placebo-controlled food challenges (DBPCFC) of 2 extensively hydrolyzed formulas in random order. If both food challenges are passed, subjects will be asked to consume the Test formula in an at-home open challenge for 7 days...
What is the current status of trial NCT02450643?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2015-04. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02450643?
The interventions under investigation include: Test extensively hydrolyzed formula (OTHER), Control extensively hydrolyzed formula (OTHER).
Who is sponsoring clinical trial NCT02450643?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.